By identifying new genetic susceptibilities of leukemias and lymphomas, these experiments revealed promising new targets for chemotherapy drugs. Subsequent experiments by other laboratories have revealed the weak spots of other types of cancer, among them colorectal cancer, cervical cancer, melanoma, ovarian cancer, and glioblastoma
